Ormeloxifene, also known as centchroman, is one of the selective estrogen receptor modulators, or SERMs, a class of medication which acts on the estrogen receptor. Ormeloxifene is a selective estrogen receptor modulator (SERM). In some parts of the body, its action is estrogenic (e.g., bones), in other parts of the body, its action is antiestrogenic (e.g., uterus, breasts). It causes an asynchrony in the menstrual cycle between ovulation and the development of the uterine lining, although its exact mode of action is not well defined. In clinical trials, it caused ovulation to occur later than it normally would in some women, ] but did not affect ovulation in the majority of women, while causing the lining of the uterus to build more slowly.

 

Brand: BCM

 

Boiling Point: 556.3ºC at 760 mmHg

 

Melting Point: 99-101°C

 

Flashing Point: 145.6ºC

 

pKa: 9.61±0.20(Predicted)

 

Solubility: Soluble in DMSO

 

Stability: Toxic nitrogen oxide fumes are expelled by thermal decomposition

 

InChi Key: XZEUAXYWNKYKPL-URLMMPGGSA-N

 

Attribute
[Chem Name]	Pyrrolidine, 1-(2-(4-(3,4-dihydro-7-methoxy-2,2-dimethyl-3-phenyl-2H-1-benzopyran-4-yl)phenoxy)ethyl)-, trans-
[Synonym]	Ormeloxifene; Centchroman; 67/20CDRI; CDRI 67/20; CDRI-67/20; CDRI6720; CDRI 6/20; CDRI-6720; CDRI67/20
[CAS No.]	31477-60-8
[EINECS]	256-846-9
[MDL No.]	MFCD00871278
[Formula]	C30H35NO3
[Molecular]	457.614
[Form]	Solid powder
[Storage]	Sealed in dry. Store at -20°C.

Goods Tag